Vasomedical Inc (VASO) 0.1591 $VASO Vasomedical

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vasomedical Inc (VASO) 0.1591 $VASO

Vasomedical Announces First Quarter 2016 Financial Results
ACCESSWIRE - Fri May 13, 8:00AM CDT
Revenue Grew 135% Year-over-Year; Adjusted EBITDA Improved to $0.71 Million

Vasomedical to Report First Quarter 2016 Results on May 13, 2016
ACCESSWIRE - Fri May 06, 8:00AM CDT
Management to Hold Investor Conference Call on May 13, 2016 at 10:00 a.m. ET

Vasomedical Announces Financial Results for Fourth Quarter and Full Year for 2015
ACCESSWIRE - Tue Mar 29, 8:00AM CDT
Net Income Increased 239% to $3.8 Million; Adjusted EBITDA Increased 205% to $5.8 Million on Record Revenue

Vasomedical to Report Fourth Quarter and Fiscal Year 2015 Results on March 29, 2016
ACCESSWIRE - Tue Mar 22, 8:00AM CDT
Management to Hold Investor Conference Call on March 29, 2016 at 10:00 a.m. ET

Shawl Lobree Joins Vasomedical As President of VasoHealthcare
ACCESSWIRE - Wed Jan 06, 8:00AM CST
PLAINVIEW, NY / ACCESSWIRE / January 6, 2016 / Vasomedical, Inc. ("Vasomedical" (OTC: VASO) today announced the appointment of Shawl Lobree as President of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vasomedical, effective January 1, 2016. VasoHealthcare has since July 1, 2010 been the exclusive representative for the sale of select GE Healthcare Diagnostic Imaging products to specific market segments in the 48 contiguous states of the United States and the District of Columbia. GE Healthcare ("GEHC" is the healthcare business of General Electric Company (NYSE: GE).
GE: 32.15 (+0.33), MDSY: 1.55 (unch)

Vasomedical Named on the 2015 Technology Fast 500 List by Deloitte Four Years in a Row
ACCESSWIRE - Mon Nov 16, 8:01AM CST
PLAINVIEW, NY / ACCESSWIRE / November 16, 2015 / Vasomedical, Inc. ("Vasomedical" (OTC BB: VASO) today announced that it has been named on the Deloitte's Technology Fast 500(TM) list for the fourth consecutive year.

Vasomedical Announces Third Quarter 2015 Results
Marketwired - Thu Nov 12, 8:00AM CST
Vasomedical, Inc. ("Vasomedical" (OTC PINK: VASO) today reported its operating results for the three months ended September 30, 2015.

Vasomedical to Report Third Quarter 2015 Results on November 12, 2015
ACCESSWIRE - Thu Nov 05, 8:00AM CST
Management to Hold Investor Conference Call on November 12, 2015 at 2:00 p.m. ET

Vasomedical Announces Relocation of Corporate Office
ACCESSWIRE - Fri Sep 25, 8:01AM CDT
WESTBURY, NY / ACCESSWIRE / September 25, 2015 / Vasomedical, Inc. ("Vasomedical" (PINKSHEETS: VASO) today announced the relocation of its corporate office, effective Monday, September 28, 2015, to 137 Commercial Street, Plainview, NY 11803. In addition to the headquarters, this facility at Plainview, Long Island will also house the operations of Vasomedical Solutions, Inc. and the New York offices of NetWolves Network Services, both of which are wholly owned subsidiaries of Vasomedical, Inc.

Multiparameter Patient Monitoring Pipeline Review 2015 - Reviews the Major Players Involved in the Development of Multiparameter Patient Monitoring
M2 - Fri Aug 14, 8:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mtjj3r/multiparameter) has announced the addition of the "Multiparameter Patient Monitoring - Pipeline Review, 2015" report to their offering. Summary This Medical Devices sector report, Multiparameter Patient Monitoring - Pipeline Review, 2015" provides an overview of Multiparameter Patient Monitoring devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Multiparameter Patient Monitoring pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Our team of industry experts. Scope - Extensive coverage of the Multiparameter Patient Monitoring products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 List of Tables and List of Figures 2 Introduction 3 Products under Development 4 Multiparameter Patient Monitoring - Pipeline Products under Development by Companies 5 Multiparameter Patient Monitoring Companies and Product Overview 6 Multiparameter Patient Monitoring- Recent Developments 7 Appendix Companies Mentioned - Azoi Inc. - Bio-Impedance General Ltd. - BioNovus Technologies, LLC - Biovotion AG - Chinese University of Hong Kong - CorTronix Biomedical Advancement Technologies, Inc. - EarlySense, Inc. - Edwards Lifesciences Corporation - Fraunhofer-Institut fur Integrierte Schaltungen - Hope College - iHealth Lab Inc - Institute for Infocomm Research - Intelesens Ltd. - Kyushu University - LifeWatch Technologies, Ltd. - Monitor-it S.A. - NeMoDevices AG - PneumoSonics Inc. - Quanttus, Inc - REALTROMINS, Inc - Rice University - Scanadu HQ - Snap40 Limited - Sotera Wireless, Inc. - Sphere Medical Limited - Toshiba Medical Systems Corporation - University of Illinois - University of Oxford - University of Technology Sydney - University of Washington - Vasomedical, Inc. - Vios Medical, Inc. - Worcester Polytechnic Institute For more information visit http://www.researchandmarkets.com/research/mt...iparameter
EW: 105.13 (+1.38)

Vasomedical Announces Second Quarter 2015 Results
Marketwired - Thu Aug 13, 8:00AM CDT
Vasomedical, Inc. ("Vasomedical" (OTCBB: VASO) today reported its operating results for the three months ended June 30, 2015.

Vasomedical Acquires Network Service Company NetWolves
ACCESSWIRE - Mon Jun 01, 8:01AM CDT
Further Diversifying Operations and Enhancing the Healthcare IT Segment

Vasomedical to Report Fourth Quarter and Fiscal Year 2014 Results on March 30, 2015
ACCESSWIRE - Mon Mar 23, 8:00AM CDT
Management to Hold Investor Conference Call on March 30, 2015 at 11:00 a.m. ET

Vasomedical, Inc. Announces Extension of Exclusive Sales Representation Agreement with GE Healthcare Through 2018
ACCESSWIRE - Wed Jan 07, 8:01AM CST
WESTBURY, NY / ACCESSWIRE / January 7, 2015 / Vasomedical, Inc. (OTCBB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products, today announces the amendment of the sales representation agreement between its subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, and GE Healthcare ("GEHC" , the healthcare business unit of General Electric Company (NYSE: GE), originally signed on May 19, 2010.
GE: 32.15 (+0.33)

Vasomedical Ranked Number 166 in Deloitte's 2014 Technology Fast 500(TM)
ACCESSWIRE - Thu Nov 13, 9:31AM CST
WESTBURY, NY / ACCESSWIRE / November 13, 2014 / Vasomedical, Inc. (OTCQB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices, today announced that, for the third consecutive year, it has been named on the Deloitte's Technology Fast 500(TM) list, with a ranking of 166, up from 207 last year.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 55

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 0

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

Colossus SSP Partners with Scope3 for Sustainable Advertising

Updated Category News Views 852

Colossus SSP Teams Up with Scope3 for Green Media Solutions Colossus Media LLC, also known as Colossus SSP, is making strides in the advertising sector by integrating with Scope3, a prominent provider of carbon emissions data. This collaboration empowers Colossus SSP to present superior green media solutions, thereby allowing brands and agencies to show greater commitment...

Continue Reading
SSC Security Services Enhances Structure Through Amalgamation

Updated Category News Views 110

SSC Security Services Corp. Completes Subsidiary Amalgamation SSC Security Services Corp., commonly referred to as SSC, is pleased to announce the successful completion of a horizontal short-form amalgamation of its wholly owned operating subsidiaries, Logixx Security Inc. and SRG Security Resource Group Inc. This strategic move is part of a larger effort to streamline...

Continue Reading
Biden Administration Takes Action to Enhance Airline Competition

Updated Category News Views 64

Biden Administration Takes a Firm Stand on Airline Competition The U.S. government is stepping up efforts to ensure fair competition in the airline industry. The Justice Department's Antitrust Division, along with the Transportation Department, has initiated a comprehensive public inquiry into the landscape of air travel competition. Prioritizing Airline Competition...

Continue Reading
Atlassian Reports Exceptional Growth in Fiscal Performance

Updated Category News Views 101

Atlassian's Strong Fiscal Performance Atlassian Corp Plc (NASDAQ: TEAM) has recently delivered its fiscal first quarter results, much to the delight of analysts and investors alike. The report highlighted impressive growth in both its cloud and data center sectors, which significantly contributed to its revenues, surpassing Wall Street's expectations. Highlights from the...

Continue Reading
Actinium Pharmaceuticals Lawsuit: What Investors Should Know Now

Updated Category News Views 238

Actinium Pharmaceuticals Class Action Lawsuit Overview In recent developments surrounding Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), investors are presented with an opportunity to lead a securities fraud class action lawsuit. This initiative is spearheaded by Rosen Law Firm, a reputable global entity vigorously advocating for investor rights. Key Details for...

Continue Reading